Home Featured Page 284

Featured

Latest

Megan Portnoy MS – Ontological Design, Psychedelic Spaces, and Integrating Rigor

The Psychedelic News Feed: October 6 – 12, 2025

Recovered or Reimagined? Samuli Kangaslampi on Psychedelics and Autobiographical Recall

Psychedelic Futures – Nowak Society featuring Joe Moore

Q2 2025: Oregon Psilocybin Services Update

Religious Use of Psychedelics in the United States

The Farmer and The Cowman Should Be Friends: Why the Pharmaceutical...

The Problem and Paradox of Bad Trips, Part 2

The Benefits of Mescaline: How An Ancient Cactus Became a Future...

Awakn Chief Medical Officer, Dr. Ben Sessa, Announces Results of the...

Mind Cure Announces Addition of Global Technology Leader Robert C. Hill...

How Psychedelics Are Helping Advance Modern Technology

Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) Closer to Pure...

Entheon Biomedical Announces Ethics Approval for In Vivo DMT Study

Spotlight on Psychedelic Pioneers: Albert Hofmann

1...283284285...299 Page 284 of 299

Megan Portnoy MS – Ontological Design, Psychedelic Spaces, and Integrating Rigor

The Psychedelic News Feed: October 6 – 12, 2025

Recovered or Reimagined? Samuli Kangaslampi on Psychedelics and Autobiographical Recall

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

Megan Portnoy MS – Ontological Design, Psychedelic Spaces, and Integrating Rigor

The Psychedelic News Feed: October 6 – 12, 2025

Recovered or Reimagined? Samuli Kangaslampi on Psychedelics and Autobiographical Recall

Psychedelic Futures – Nowak Society featuring Joe Moore

Q2 2025: Oregon Psilocybin Services Update

Religious Use of Psychedelics in the United States

The Farmer and The Cowman Should Be Friends: Why the Pharmaceutical...

The Problem and Paradox of Bad Trips, Part 2

The Benefits of Mescaline: How An Ancient Cactus Became a Future...

Awakn Chief Medical Officer, Dr. Ben Sessa, Announces Results of the...

Mind Cure Announces Addition of Global Technology Leader Robert C. Hill...

How Psychedelics Are Helping Advance Modern Technology

Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) Closer to Pure...

Entheon Biomedical Announces Ethics Approval for In Vivo DMT Study

Spotlight on Psychedelic Pioneers: Albert Hofmann

EDITOR PICKS

Megan Portnoy MS – Ontological Design, Psychedelic Spaces, and Integrating Rigor

The Psychedelic News Feed: October 6 – 12, 2025

Recovered or Reimagined? Samuli Kangaslampi on Psychedelics and Autobiographical Recall

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY